4The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J]. Hum Reprod,2004,19: 41-47.
5Goodarzi M, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome [ J ]. Best Prac Res Clin Endocrinol Metab,2006,20 : 193-205.
6Heinonen S, Korhonen S, Hippelainen M,et al. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a eontroUed, populatian-based study[ J]. Am J Obstet Gyneeol, 2001,184 : 289-296.
7Salmi DJ. Screening for and treatment of PCOS in teenagers[ J]. Exp Biol Med, 2004,229,369-377.
8Carlos M, Edgardo GH, Edgar B, et al. Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome [ J ]. Fertil Steril, 2003,80(6) :1466-1472.
9Leo VDE, Marca ALA, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome [ J ]. Endocr Rev, 2003, 24(5): 633-667.
10Jeffrey C,Mickey S,Coffler.Polycystic ovary syndrome:early detection in the adolescent[J].Clin Obstet Gynecol,2007,50(1):178-187.
